Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 1 | 2022 | 25 | 0.840 |
Why?
|
| Chickens | 1 | 2022 | 523 | 0.790 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 8 | 0.550 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 488 | 0.490 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 533 | 0.480 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 674 | 0.470 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 1392 | 0.440 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 2086 | 0.390 |
Why?
|
| Epithelial Cells | 2 | 2015 | 1818 | 0.380 |
Why?
|
| Cell Proliferation | 2 | 2015 | 7226 | 0.230 |
Why?
|
| Heterografts | 2 | 2022 | 733 | 0.220 |
Why?
|
| Anoctamin-1 | 1 | 2022 | 2 | 0.220 |
Why?
|
| Chick Embryo | 1 | 2022 | 242 | 0.200 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 10331 | 0.190 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 8 | 0.180 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 27 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 7222 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 741 | 0.160 |
Why?
|
| Smoothened Receptor | 2 | 2015 | 52 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 15694 | 0.160 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 140 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 245 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2015 | 11965 | 0.160 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2019 | 2341 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2019 | 575 | 0.140 |
Why?
|
| Progesterone | 1 | 2018 | 513 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2019 | 448 | 0.140 |
Why?
|
| Cisplatin | 1 | 2022 | 2432 | 0.120 |
Why?
|
| Estrogens | 1 | 2018 | 751 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3981 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 840 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 4892 | 0.110 |
Why?
|
| Animals | 6 | 2022 | 59536 | 0.110 |
Why?
|
| Mice | 5 | 2022 | 34495 | 0.110 |
Why?
|
| Breast | 1 | 2018 | 1344 | 0.100 |
Why?
|
| Disease Progression | 2 | 2019 | 6682 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2011 | 128 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 3230 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 839 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 4143 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 3719 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 3976 | 0.070 |
Why?
|
| Humans | 7 | 2022 | 261506 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 3821 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2022 | 60 | 0.050 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 463 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 347 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 69 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 96 | 0.040 |
Why?
|
| Female | 4 | 2022 | 141928 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 127 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 71 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 14289 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 164 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 1541 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 760 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1077 | 0.040 |
Why?
|
| Metabolome | 1 | 2019 | 344 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 478 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 14551 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 5114 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 6086 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 1399 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 1859 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 262 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 557 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 424 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 509 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 383 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 752 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12221 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2074 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 1304 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 13658 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8873 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4557 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6295 | 0.010 |
Why?
|
| Male | 1 | 2019 | 123000 | 0.010 |
Why?
|